Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens
Recruiting
N/A
Interventional Study
Ventilator Associated Pneumonia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 265 (estimated)
- Sponsor
- CHU de Reims · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Ventilator-associated pneumonia (VAP) remains one of the main nosocomial infections acquired in the intensive care unit (ICU). VAP is pneumonia occurring 48 hours after intubation. Today, bronchoalveolar lavage (BAL) is used for microbiological diagnosis, with bacterial culture and antibiotic susceptibility results within 48 to 72 hours. Multiplex PCR can detect DNA of a number of bacteriae, as we…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
inclusion criteria :
* Adult patients, hospitalized in intensive care unit
* on mechanical ventilation for at least 48 hours
* Suspected VAP
* With an indication for bronchoalveolar lavage (BAL)
exclusion criteria :
* Patients under legal protection or without social security coverage
* Pregnant …
Contacts